Order Article Reprints

Dechsupa N, Khamto N, Chawapun P, Siriphong S, Innuan P, Suwan A, Luangsuep T, Photilimthana N, Maita W, Thanacharttanatchaya R, et al. Pentagalloyl Glucose-Targeted Inhibition of P-Glycoprotein and Re-Sensitization of Multidrug-Resistant Leukemic Cells (K562/ADR) to Doxorubicin: In Silico and Functional Studies. Pharmaceuticals. 2023; 16(9):1192. https://doi.org/10.3390/ph16091192

Dechsupa, Nathupakorn, Nopawit Khamto, Pornthip Chawapun, Sadanon Siriphong, Phattarawadee Innuan, Authaphinya Suwan, Thitiworada Luangsuep, Nichakorn Photilimthana, Witchayaporn Maita, Rossarin Thanacharttanatchaya, and et al. 2023. "Pentagalloyl Glucose-Targeted Inhibition of P-Glycoprotein and Re-Sensitization of Multidrug-Resistant Leukemic Cells (K562/ADR) to Doxorubicin: In Silico and Functional Studies" Pharmaceuticals 16, no. 9: 1192. https://doi.org/10.3390/ph16091192

Dechsupa, N., Khamto, N., Chawapun, P., Siriphong, S., Innuan, P., Suwan, A., Luangsuep, T., Photilimthana, N., Maita, W., Thanacharttanatchaya, R., Sangthong, P., Meepowpan, P., Udomtanakunchai, C., & Kantapan, J. (2023). Pentagalloyl Glucose-Targeted Inhibition of P-Glycoprotein and Re-Sensitization of Multidrug-Resistant Leukemic Cells (K562/ADR) to Doxorubicin: In Silico and Functional Studies. Pharmaceuticals, 16(9), 1192. https://doi.org/10.3390/ph16091192